Scholarly references (selected)
This curated list emphasizes reputable cardiology journals and studies commonly cited in EP practice. For clinical decisions, follow your treating team and the most current guidelines.
| Journal | Study type | Key finding (why it matters) | Link |
|---|---|---|---|
| Open access review | Review (CTI flutter ablation) | Modern review: typical CTI flutter mechanisms, ablation approach, outcomes and recurrence; beyond “simple line” concepts. | Open |
| ESC (Guideline hub) | Clinical guideline | Guideline recommendations for SVT, including typical flutter and CTI ablation indications and approach. | Open |
| Heart Rhythm Case Reports | Clinical overview (full text) | Practical overview of CTI ablation for atrial flutter and procedural concepts. | Open |
| Frontiers in Cardiovascular Medicine | Registry / outcomes (open access) | Clinical outcomes and recurrence context involving typical flutter and CTI ablation, including relationship with AF strategies. | Open |
| PMC (open access) | Outcomes analysis (open access) | Open-access mirror of clinical outcomes/recurrence context relating to CTI ablation and atrial arrhythmia recurrence. | Open |
| Scandinavian Cardiovascular Journal | Comparative outcomes (full text) | CTI anatomy/morphology effects; CRYO vs RF performance context for typical flutter ablation. | Open |
| Europace | Feasibility study (PFA, open access) | Early feasibility and acute results for pulsed-field technology applied to CTI region (emerging modality). | Open |
| PMC (open access) | Clinical outcomes (PFA, open access) | Safety, efficacy and mid-term outcomes of PFA for CTI-dependent flutter. | Open |
| PMC (open access) | Technique/outcomes (open access) | Evaluation of high-power approaches in typical flutter ablation and associated outcomes. | Open |
| Authorea | Systematic literature review (open access) | Systematic review summarizing PFA data for CTI-dependent flutter (emerging evidence base). | Open |
| J Am Coll Cardiol (JACC) | Population-based cohort (epidemiology) | Overall incidence 88/100,000 person‑years; rises sharply with age; ~2.5× higher in men; HF and COPD increase risk. | Open |
| Circulation: Arrhythmia and Electrophysiology | Outcomes study (technique / recurrence) | Long‑term outcomes after CTI ablation; larger tip/irrigated RF associated with lower flutter recurrence (e.g., ~6.7% vs 13.8%). | Open |
| JACC: Clinical Electrophysiology | Systematic review & meta‑analysis | Quantifies incidence of atrial fibrillation after successful typical flutter ablation (AF remains common over follow‑up). | Open |
| Europace | Cohort (new‑onset AF after CTI) | New‑onset AF develops in a significant proportion after CTI ablation; caution about stopping anticoagulation solely because flutter is ablated. | Open |
| Circulation | Randomized trial (strategy in AF+AFL) | In patients with AF plus typical flutter, randomized comparison of pulmonary vein–LA junction disconnection strategy vs standard approaches (strategy paper). | Open |
| Heart Rhythm | Prospective randomized trial | Tests hypothesis that pulmonary vein triggers may initiate AFL/AF; evaluates PVI strategy in patients with typical flutter without prior AF. | Open |
| JAMA | Randomized trial (ablation vs AAD; AF context) | Radiofrequency ablation vs antiarrhythmic drugs reduced recurrent atrial tachyarrhythmias at 2 years (high‑impact RCT supporting ablation). | Open |
| N Engl J Med | Randomized trial (energy modality; AF context) | ADVENT: pulsed‑field ablation noninferior to thermal ablation for paroxysmal AF (relevant to energy technologies discussed in EP labs). | Open |
| Europace | Guideline document (ESC) | ESC guidance for AF/AFL management including anticoagulation around cardioversion and rhythm control frameworks. | Open |
| J Am Heart Assoc (JAHA) | Epidemiology / genetics (atrial arrhythmia predisposition) | Large cohort work addressing associations and predisposition signals in atrial arrhythmias (context for genetics section). | Open |
How to use these references
- Epidemiology: incidence and predictors in general populations.
- CTI ablation outcomes: long‑term durability, recurrence predictors, technique refinements.
- AF after flutter: informs surveillance and anticoagulation decisions post‑flutter ablation.
- Energy modalities: contextual evidence for RF, cryo, and newer non‑thermal approaches (mostly studied in AF).